Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -157,848 | -88,015 | -314,248 | -229,864 | -152,893 |
| Depreciation Amortization | 3,267 | 2,361 | 17,074 | 13,843 | 9,921 |
| Accounts receivable | -5,248 | -10,803 | 5,455 | 1,485 | -2,817 |
| Accounts payable and accrued liabilities | 4,262 | 5,068 | 1,025 | 1,511 | 1,331 |
| Other Working Capital | -38,622 | -43,129 | -53,972 | -48,290 | -33,707 |
| Other Operating Activity | 57,757 | 39,827 | 81,455 | 58,670 | 38,573 |
| Operating Cash Flow | $-136,432 | $-94,691 | $-263,211 | $-202,645 | $-139,592 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -165,155 | -68,832 | 133,012 | 47,526 | -10,571 |
| PPE Investments | -5,989 | -3,721 | -16,750 | -11,846 | -7,657 |
| Purchase Sale Intangibles | N/A | N/A | -179 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -179 | 0 | 0 |
| Investing Cash Flow | $-171,144 | $-72,553 | $116,083 | $35,680 | $-18,228 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -911 | -446 | -1,608 | -1,180 | -770 |
| Common Stock Issued | 199,021 | 196,435 | 11,230 | 9,983 | 6,440 |
| Other Financing Activity | -6,836 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $191,274 | $195,989 | $9,622 | $8,803 | $5,670 |
| Beginning Cash Position | 328,311 | 328,311 | 465,817 | 465,817 | 465,817 |
| End Cash Position | 212,009 | 357,056 | 328,311 | 307,655 | 313,667 |
| Net Cash Flow | $-116,302 | $28,745 | $-137,506 | $-158,162 | $-152,150 |
| Free Cash Flow | |||||
| Operating Cash Flow | -136,432 | -94,691 | -263,211 | -202,645 | -139,592 |
| Capital Expenditure | -5,989 | -3,721 | -16,750 | -11,846 | -7,657 |
| Free Cash Flow | -142,421 | -98,412 | -279,961 | -214,491 | -147,249 |